TCM
BIIB icon

Tran Capital Management’s Biogen BIIB Stock Holding History

Tran Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-1,000
Closed -$315K – 100
2014
Q2 		$315K Hold
1,000
– – 0.01% 92
2014
Q1 		$306K Sell
1,000
-500
-33% -$159K 0.01% 94
2013
Q4 		$419K Buy
+1,500
New +$388K 0.01% 87

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Tran Capital Management's BIIB Position: Q3 2014 in Review

Tran Capital Management sold out of Biogen (BIIB) in Q3 2014, closing a stake of 1,000 shares — an estimated $315K sold.

Tran Capital Management first reported a position in BIIB in Q4 2013 and held it in 3 quarters. The position peaked at $419K in Q4 2013. 818 funds tracked by Wall St. Rank hold BIIB as of Q3 2014.

  • Tran Capital Management reported no remaining Biogen position as of Q3 2014 after selling out during the quarter.
  • Tran Capital Management sold 1,000 Biogen shares in Q3 2014, an estimated $315K.
  • Tran Capital Management first reported a position in Biogen in Q4 2013 and held it in 3 quarters.
  • Tran Capital Management's Biogen position peaked at $419K in Q4 2013.
  • 818 funds tracked by Wall St. Rank held Biogen as of Q3 2014.

Based on Tran Capital Management's 13F filing for Q3 2014, filed 30 Oct 2014.